These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23083608)

  • 21. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
    Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
    AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproducibility of total choline/water ratios in mouse U87MG xenograft tumors by 1H-MRS.
    Zhu M; Fischl AS; Trowbridge MA; Shannon HE
    J Magn Reson Imaging; 2012 Aug; 36(2):459-67. PubMed ID: 22517495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of evidence-based medicine on magnetic resonance spectroscopy.
    Lin AP; Tran TT; Ross BD
    NMR Biomed; 2006 Jun; 19(4):476-83. PubMed ID: 16763969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
    Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
    NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast nosologic imaging of the brain.
    De Vos M; Laudadio T; Simonetti AW; Heerschap A; Van Huffel S
    J Magn Reson; 2007 Feb; 184(2):292-301. PubMed ID: 17118683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary effect of H MRS in diagnosis of suprasellar tumors.
    Faghih Jouibari M; Ghodsi SM; Akhlaghpoor S; Mehrazin M; Saadat S; Khoshnevisan A; Padeganeh T; Aoude A
    Clin Imaging; 2012; 36(6):810-5. PubMed ID: 23154013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of feature-reduced MR spectroscopic and MR imaging data for improved brain tumor classification.
    Simonetti AW; Melssen WJ; Szabo de Edelenyi F; van Asten JJ; Heerschap A; Buydens LM
    NMR Biomed; 2005 Feb; 18(1):34-43. PubMed ID: 15657908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo proton spectroscopy of giant cell tumor of the bone.
    Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR
    AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR-spectroscopy at 1.5 tesla and 3 tesla. Useful? A systematic review and meta-analysis.
    Baltzer PA; Dietzel M; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S6-9. PubMed ID: 23083604
    [No Abstract]   [Full Text] [Related]  

  • 33. MALDI-imaging: what can be expected?
    von Eggeling F; Crecelius AC; Schubert US; Guntinas-Lichius O; Ernst G
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S183-4. PubMed ID: 23083583
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperpolarized C-13 studies of cancer metabolism in animal models. Hype or real?
    Lenkinski RE
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S85-6. PubMed ID: 23083616
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular and functional imaging of cancer: advances in MRI and MRS.
    Pathak AP; Gimi B; Glunde K; Ackerstaff E; Artemov D; Bhujwalla ZM
    Methods Enzymol; 2004; 386():3-60. PubMed ID: 15120245
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
    Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
    Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
    NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy.
    Esseridou A; Di Leo G; Sconfienza LM; Caldiera V; Raspagliesi F; Grijuela B; Hanozet F; Podo F; Sardanelli F
    Invest Radiol; 2011 Jun; 46(6):377-82. PubMed ID: 21467947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences.
    Caivano R; Cirillo P; Balestra A; Lotumolo A; Fortunato G; Macarini L; Zandolino A; Vita G; Cammarota A
    J Med Imaging Radiat Oncol; 2012 Dec; 56(6):606-16. PubMed ID: 23210579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.